Kinase 2020:
 

9th RSC / SCI symposium on kinase inhibitor design

 

Monday-Tuesday, 1st-2nd June 2020

The Francis Crick Institute, London, UK

 

 

Registration is not yet open

 

Twitter hashtag - #Kinase20

 

Downloads and Links

First announcement

Oral and poster abstract template - closing dates are 18th December (oral) and 17th April (poster)

 

Venue location weblink

Accommodation booking weblink - release date is 3rd April

 

RSC website

SCI website

 

Synopsis

With more than 49 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 9th RSC/SCI symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

 

Programme Themes
This event will bring together industrial and academic experts representing many of the leading institutions in kinase drug discovery, to discuss a selection of new and emerging topics within the fields of kinase therapeutics for oncology and non-oncology therapies, and foster discussions within the wider industry through networking events such as poster sessions and industrial exhibitions.

 

Who should attend?
This event is aimed at all scientists interested in furthering their knowledge of kinases. It will also have wider appeal to members of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry. 

 

Call for Papers

Abstracts are invited for oral and poster presentation. Posters will be displayed throughout the meeting, and a dedicated poster session. There will also be an option for a flash oral presentation (two minutes, single slide).

 

Please download an abstract template here.

Closing dates for submissions are 18th December (oral) and 17th April (poster).

 

Confirmed Speakers

Sam Butterworth, The University of Manchester, UK

 

Presentation title to be confirmed

John Harling, GlaxoSmithKline, UK


X-ray structures and feasibility assessment of CLK2 inhibitors for Phelan McDermid syndrome
Andreas Lerchner, Novartis, US


Structure-based drug design of selective WEE1 inhibitors
Tom Pesnot, Concept Life Sciences, UK
 

Fragment-derived, selective and orally-active inhibitors of DYRK1A and DYRK1B
Lee Walmsley, Vernalis Research, UK
 

Presentation title to be confirmed
Mike Waring, Newcastle University, UK

 

Registration, Fees and Bursaries

Registration will open in late summer/early autumn. Discounted rates will be available for RSC and SCI student members, and some student bursaries will also be available.
 

Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Member is paid-up member of the RSC or SCI.

Some student bursaries will be available, and the closing date is 15th April. 

 

Cancellation Policy

In the event of cancellation by 17th May 2020, 80% of the fee paid will be refunded. Cancellations must be received in writing. Refunds will not be possible after that date although substitutions are possible at any time. In the unlikely event of cancellation of the meeting, fees paid will be refunded in full.
 

Exhibition

There will be a relevant trade exhibition.  The charge will include:

- stand space measuring 3 m wide x 2 m deep

- trestle table measuring 1.8 m wide x .8 m deep

- access to electricity and wi-fi

- inclusion of a promotional slide to be played on rotation on the main screen during breaks
- logo acknowledgement in the delegate handbook

- one full delegate with all catering.

 

Delegate pack inserts may be booked at £250 - no more than two sheets of A4 fixed together.

 

Sponsors

We are grateful to our confirmed sponsors

 

 

 


 

 

We are grateful to EFMC for supporting this event

 

Venue and Travel

Address:  The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK

 

Centrally located adjacent to King’s Cross St Pancras railway station, the Institute is readily accessible by public transport.

 

Venue location weblink

 

Accommodation

A number of bedrooms have been held (via InCorporate Venues) at the Travelodge Kings Cross Royal Scot and the Travelodge Central Euston.  Rooms are available to book online via this link.  Details are below.

 

Kings Cross Royal Scot, WC1X 9DT
£50.70    Sunday, 31st May per room + £6.30 per person for breakfast
£86.75    Monday, 1st June per room + £6.30 per person for breakfast

Release date: 3rd April 2020 at midday
 

Travelodge Central Euston, NW1 1DJ

£81.60     Sunday, 31st May per room + £6.30 per person for breakfast
£153.70    Monday, 1st June per room + £6.30 per person for breakfast
Release date: 3rd April 2020 at midday
 

Booking weblink here
Any unbooked bedrooms will be released at midday on 30th April , and cancellation will not be possible thereafter.

 

Organising Committee

John CummingF Hoffmann-La Roche
John HarrisCJH Consultants
Pascal Savy (chair)Charles River
Mihiro SunoseSygnature Discovery
Richard WardAstraZeneca
Douglas WilliamsonVernalis Research

     

Secretariat Contact

Maggi Churchouse Events, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK

E-mail Maggi Churchouse

Telephone: +44 (0)1359 221004

 

Registration is not yet open